Alterations in Tau Metabolism in ALS and ALS-FTSD
There is increasing acceptance that amyotrophic lateral sclerosis (ALS), classically considered a neurodegenerative disease affecting almost exclusively motor neurons, is syndromic with both clinical and biological heterogeneity. This is most evident in its association with a broad range of neuropsy...
Main Authors: | Michael J. Strong, Neil S. Donison, Kathryn Volkening |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2020.598907/full |
Similar Items
-
Phosphorylation of Threonine 175 Tau in the Induction of Tau Pathology in Amyotrophic Lateral Sclerosis—Frontotemporal Spectrum Disorder (ALS-FTSD). A Review
by: Alexander J. Moszczynski, et al.
Published: (2018-04-01) -
Synergistic toxicity in an in vivo model of neurodegeneration through the co-expression of human TDP-43M337V and tauT175D protein
by: Alexander J. Moszczynski, et al.
Published: (2019-11-01) -
The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
by: Britt A. Berning, et al.
Published: (2019-04-01) -
TDP-43 pathology in chronic traumatic encephalopathy
by: Barnes, Douglas
Published: (2016) -
Novel miR-b2122 regulates several ALS-related RNA-binding proteins
by: Zachary C. E. Hawley, et al.
Published: (2017-10-01)